Biogen Inc Stock Price History
BIIB Stock | USD 215.50 6.60 3.16% |
Below is the normalized historical share price chart for Biogen Inc extending back to September 17, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biogen stands at 215.50, as last reported on the 30th of April, with the highest price reaching 218.86 and the lowest price hitting 208.54 during the day.
If you're considering investing in Biogen Stock, it is important to understand the factors that can impact its price. Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Risk Adjusted Performance of (0.08), mean deviation of 1.18, and Standard Deviation of 1.73 to double-check the risk estimate we provide.
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B). . At present, Biogen's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 31.81, whereas Price To Sales Ratio is forecasted to decline to 3.62. Biogen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of September 1991 | 200 Day MA 243.3142 | 50 Day MA 212.7094 | Beta (0.01) |
Biogen |
Sharpe Ratio = -0.1421
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BIIB |
Estimated Market Risk
1.77 actual daily | 15 85% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding Biogen to a well-diversified portfolio.
Price Book 1.9465 | Enterprise Value Ebitda 17.2165 | Price Sales 2.9289 | Shares Float 145.1 M | Wall Street Target Price 286.1 |
Biogen Stock Price History Chart
There are several ways to analyze Biogen Stock price data. The simplest method is using a basic Biogen candlestick price chart, which shows Biogen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | February 1, 2024 | 247.83 |
Lowest Price | April 18, 2024 | 190.52 |
Biogen April 30, 2024 Stock Price Synopsis
Various analyses of Biogen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biogen Stock. It can be used to describe the percentage change in the price of Biogen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biogen Stock.Biogen Accumulation Distribution | 96,947 | |
Biogen Price Rate Of Daily Change | 1.03 | |
Biogen Price Daily Balance Of Power | 0.64 | |
Biogen Price Action Indicator | 5.10 |
Biogen April 30, 2024 Stock Price Analysis
Biogen Stock Price History Data
The price series of Biogen for the period between Wed, Jan 31, 2024 and Tue, Apr 30, 2024 has a statistical range of 57.31 with a coefficient of variation of 7.35. The prices are distributed with arithmetic mean of 219.82. The median price for the last 90 days is 219.36. The company had 3:1 stock split on 18th of January 2001.Open | High | Low | Close | Volume | ||
04/29/2024 | 208.99 | 218.86 | 208.54 | 215.50 | 2,056,000 | |
04/26/2024 | 201.22 | 210.83 | 199.10 | 208.90 | 1,881,500 | |
04/25/2024 | 201.21 | 205.36 | 198.11 | 202.46 | 1,589,471 | |
04/24/2024 | 199.18 | 205.75 | 198.97 | 201.99 | 3,259,702 | |
04/23/2024 | 193.34 | 195.86 | 192.75 | 193.18 | 1,437,456 | |
04/22/2024 | 196.19 | 196.78 | 193.23 | 194.11 | 1,119,500 | |
04/19/2024 | 190.72 | 194.53 | 189.44 | 194.38 | 1,599,173 | |
04/18/2024 | 191.75 | 192.55 | 189.52 | 190.52 | 1,481,410 | |
04/17/2024 | 195.37 | 195.55 | 192.01 | 192.16 | 1,320,234 | |
04/16/2024 | 196.20 | 197.73 | 194.94 | 195.15 | 871,712 | |
04/15/2024 | 198.73 | 199.53 | 196.45 | 196.80 | 1,153,671 | |
04/12/2024 | 204.23 | 205.24 | 197.78 | 198.18 | 1,245,900 | |
04/11/2024 | 202.76 | 204.74 | 200.92 | 203.68 | 1,019,100 | |
04/10/2024 | 203.00 | 203.99 | 200.65 | 201.55 | 872,232 | |
04/09/2024 | 205.02 | 209.06 | 205.02 | 206.52 | 969,000 | |
04/08/2024 | 203.77 | 205.77 | 202.91 | 204.95 | 723,651 | |
04/05/2024 | 204.28 | 205.19 | 202.18 | 203.87 | 942,354 | |
04/04/2024 | 207.24 | 210.00 | 205.22 | 205.30 | 776,040 | |
04/03/2024 | 207.71 | 208.70 | 205.36 | 206.38 | 870,310 | |
04/02/2024 | 213.37 | 213.37 | 207.58 | 207.64 | 1,461,772 | |
04/01/2024 | 215.63 | 215.69 | 212.56 | 214.83 | 823,955 | |
03/28/2024 | 217.36 | 217.57 | 214.00 | 215.63 | 1,912,200 | |
03/27/2024 | 213.75 | 216.34 | 212.92 | 216.34 | 1,250,000 | |
03/26/2024 | 216.15 | 216.67 | 211.02 | 212.02 | 1,589,830 | |
03/25/2024 | 217.77 | 218.26 | 215.59 | 216.69 | 725,898 | |
03/22/2024 | 221.30 | 221.30 | 215.36 | 218.10 | 1,048,165 | |
03/21/2024 | 219.33 | 221.74 | 217.95 | 220.75 | 994,897 | |
03/20/2024 | 217.18 | 219.36 | 216.53 | 218.15 | 808,061 | |
03/19/2024 | 218.35 | 219.02 | 215.59 | 218.63 | 1,501,773 | |
03/18/2024 | 220.34 | 220.56 | 217.64 | 219.40 | 1,338,161 | |
03/15/2024 | 219.15 | 221.31 | 216.80 | 219.31 | 2,402,070 | |
03/14/2024 | 225.25 | 225.25 | 218.58 | 219.62 | 1,565,998 | |
03/13/2024 | 228.76 | 229.90 | 224.93 | 226.56 | 1,481,100 | |
03/12/2024 | 229.34 | 229.75 | 225.35 | 227.36 | 1,068,900 | |
03/11/2024 | 223.30 | 230.22 | 223.24 | 230.07 | 1,218,226 | |
03/08/2024 | 225.45 | 228.36 | 221.98 | 223.24 | 1,658,043 | |
03/07/2024 | 219.92 | 219.92 | 216.69 | 219.36 | 1,150,268 | |
03/06/2024 | 217.47 | 219.99 | 216.80 | 217.56 | 1,212,060 | |
03/05/2024 | 219.65 | 221.50 | 216.50 | 217.23 | 890,390 | |
03/04/2024 | 221.17 | 222.92 | 219.76 | 221.02 | 1,083,626 | |
03/01/2024 | 217.46 | 222.02 | 215.35 | 220.95 | 1,085,371 | |
02/29/2024 | 221.76 | 224.00 | 216.70 | 216.99 | 1,917,469 | |
02/28/2024 | 222.25 | 224.12 | 221.00 | 221.74 | 1,038,429 | |
02/27/2024 | 223.72 | 224.87 | 220.20 | 223.94 | 983,079 | |
02/26/2024 | 222.52 | 224.99 | 222.00 | 223.71 | 774,464 | |
02/23/2024 | 223.43 | 225.80 | 221.50 | 223.32 | 911,025 | |
02/22/2024 | 221.23 | 223.22 | 218.69 | 222.48 | 901,075 | |
02/21/2024 | 221.49 | 223.41 | 219.00 | 221.11 | 1,055,003 | |
02/20/2024 | 217.56 | 220.25 | 215.68 | 219.21 | 1,919,847 | |
02/16/2024 | 221.15 | 221.75 | 217.53 | 219.08 | 1,768,111 | |
02/15/2024 | 221.15 | 225.00 | 220.07 | 223.35 | 1,307,754 | |
02/14/2024 | 227.01 | 227.99 | 220.56 | 220.74 | 2,220,506 | |
02/13/2024 | 235.64 | 237.00 | 225.28 | 226.65 | 3,403,289 | |
02/12/2024 | 239.45 | 244.95 | 239.45 | 244.74 | 962,049 | |
02/09/2024 | 239.88 | 241.36 | 238.90 | 240.98 | 689,850 | |
02/08/2024 | 239.89 | 240.54 | 237.52 | 240.30 | 743,734 | |
02/07/2024 | 246.44 | 246.44 | 240.54 | 240.54 | 773,768 | |
02/06/2024 | 241.00 | 245.88 | 239.96 | 245.55 | 1,304,753 | |
02/05/2024 | 242.21 | 245.23 | 240.50 | 241.84 | 858,604 | |
02/02/2024 | 245.93 | 246.39 | 241.53 | 243.72 | 861,428 | |
02/01/2024 | 245.40 | 249.33 | 240.00 | 247.83 | 955,464 |
About Biogen Stock history
Biogen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biogen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biogen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biogen stock prices may prove useful in developing a viable investing in Biogen
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 145.6 M | 283 M | |
Net Income Applicable To Common Shares | 3.5 B | 2 B |
Biogen Quarterly Net Working Capital |
|
Biogen Stock Technical Analysis
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Biogen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biogen's price direction in advance. Along with the technical and fundamental analysis of Biogen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biogen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.47) | |||
Treynor Ratio | (0.20) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.